急性冠脉综合征后心血管康复:终点、生物标志物与临床实践
该综述阐述心脏康复(CR)是急性冠脉综合征(ACS)后二级预防的核心多学科干预,可降低死亡率、复发事件和住院率,改善生活质量与功能容量。近期数字健康、远程医疗、新型药物及身心干预拓展了CR范围,但全球可及性与实施差异仍显著,需协调转诊与个体化策略。
要点
- CR是ACS后二级预防核心,降低死亡率、复发事件与住院率。
- 数字健康与远程医疗可改善CR可及性与依从性。
- PCSK9抑制剂等新型药物整合入CR有助降低残余风险。
核心结论
- CR是ACS后二级预防的核心多学科干预,可降低死亡率、复发事件和住院率,并改善生活质量与功能容量。
- CR获益超越身体康复,包括减轻全身炎症、减缓不良心脏重构和促进长期行为改变。
- 尽管CR范围已拓展,但可及性仍有限且地区间实施与参与差异显著,需协调转诊与个体化策略。
研究设计与样本
- 综述,未报告系统检索范围与样本量。
主要发现
- CR降低死亡率、复发事件和住院率,并改善生活质量与功能容量。
- 数字健康工具、远程医疗和混合交付模式改善CR可及性与依从性,尤其在资源有限环境。
- PCSK9抑制剂、inclisiran及靶向脂蛋白(a)和炎症的药物整合入CR有助降低残余风险。
- 瑜伽、太极和八段锦等身心干预为老年或体能下降患者提供额外生理和心理获益。
- 心肺运动试验和通气阈值等高级功能评估有助于个体化风险分层和训练处方。
临床怎么用
- 将CR作为ACS后二级预防的核心多学科干预,整合医学管理、结构化运动、心理支持和生活方式改变。
- 在资源有限环境可采用数字健康、远程医疗和混合交付模式改善CR可及性与依从性。
- 将PCSK9抑制剂、inclisiran及靶向脂蛋白(a)和炎症的药物整合入CR以降低残余风险。
- 对老年或体能下降患者可考虑瑜伽、太极和八段锦等身心干预。
- 使用心肺运动试验和通气阈值进行个体化风险分层和训练处方。
局限性
- CR可及性仍有限,地区间实施与参与差异显著。
- 需协调转诊系统、多学科协作和以患者为中心的策略来弥补差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiac rehabilitation (CR) is a multidisciplinary intervention central to secondary prevention after acute coronary syndromes (ACSs), combining medical management, structured exercise, psychological support and lifestyle modification. CR reduces mortality, recurrent events and hospitalisations, while improving quality of life and functional capacity. Its benefits extend beyond physical recovery to include mitigation of systemic inflammation, attenuation of adverse cardiac remodelling and promotion of long-term behavioural change. Recent advances have expanded the scope of CR. Digital health tools, telemedicine and hybrid delivery models have improved accessibility and adherence, particularly in resource-limited settings. Pharmacological innovations, such as PCSK9 inhibitors, inclisiran and agents targeting lipoprotein(a) and inflammation, contribute to residual risk reduction when integrated into CR. Mind-body interventions, including yoga, tai chi and Qigong Baduanjin, offer additional physiological and psychological benefits, especially in elderly or deconditioned patients. The use of advanced functional assessments, including cardiopulmonary exercise testing and ventilatory thresholds, facilitates personalised risk stratification and training prescription. Despite these developments, access to CR remains limited, with significant variability in implementation and participation across regions. Addressing these gaps requires harmonised referral systems, multidisciplinary coordination and patient-centred strategies. Ongoing research should focus on integrating emerging therapies and technologies to enhance personalisation, promote equity and expand CR applications across broader patient populations.
引用
- Cutore, Faro, Raffo, et al. Post-acute coronary syndrome cardiovascular rehabilitation: insights into endpoints, biomarkers and clinical practice. Heart. 2026. PMID: 41850784. doi:10.1136/heartjnl-2025-327535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。